HEADER OXIDOREDUCTASE 17-JUN-14 4UPN TITLE STRUCTURE OF RAT NEURONAL NITRIC OXIDE SYNTHASE HEME DOMAIN IN COMPLEX TITLE 2 WITH N,N''-{[(2S)-3-AMINOPROPANE-1,2-DIYL]BIS(OXYMETHANEDIYLBENZENE- TITLE 3 3,1-DIYL)}DITHIOPHENE-2-CARBOXIMIDAMIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: NEURONAL NITRIC OXIDE SYNTHASE; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: HEME DOMAIN, RESIDUES 297-718; COMPND 5 EC: 1.14.13.39; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: RATTUS NORVEGICUS; SOURCE 3 ORGANISM_COMMON: NORWAY RAT; SOURCE 4 ORGANISM_TAXID: 10116; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_VECTOR: PCWORI KEYWDS OXIDOREDUCTASE, INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR H.LI,T.L.POULOS REVDAT 4 08-MAY-24 4UPN 1 REMARK LINK REVDAT 3 24-SEP-14 4UPN 1 JRNL REVDAT 2 03-SEP-14 4UPN 1 JRNL REVDAT 1 20-AUG-14 4UPN 0 JRNL AUTH Q.JING,H.LI,L.J.ROMAN,P.MARTASEK,T.L.POULOS,R.B.SILVERMAN JRNL TITL COMBINATION OF CHIRAL LINKERS WITH THIOPHENECARBOXIMIDAMIDE JRNL TITL 2 HEADS TO IMPROVE THE SELECTIVITY OF INHIBITORS OF NEURONAL JRNL TITL 3 NITRIC OXIDE SYNTHASE. JRNL REF BIOORG.MED.CHEM.LETT. V. 24 4504 2014 JRNL REFN ISSN 0960-894X JRNL PMID 25149509 JRNL DOI 10.1016/J.BMCL.2014.07.079 REMARK 2 REMARK 2 RESOLUTION. 2.09 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.7.0029 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.09 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 49.38 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 97.6 REMARK 3 NUMBER OF REFLECTIONS : 53478 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.201 REMARK 3 R VALUE (WORKING SET) : 0.199 REMARK 3 FREE R VALUE : 0.245 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.900 REMARK 3 FREE R VALUE TEST SET COUNT : 2772 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.09 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.15 REMARK 3 REFLECTION IN BIN (WORKING SET) : 3507 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 87.38 REMARK 3 BIN R VALUE (WORKING SET) : 0.3110 REMARK 3 BIN FREE R VALUE SET COUNT : 150 REMARK 3 BIN FREE R VALUE : 0.3830 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 6659 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 201 REMARK 3 SOLVENT ATOMS : 213 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 35.16 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 57.04 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 9.09000 REMARK 3 B22 (A**2) : -3.44000 REMARK 3 B33 (A**2) : -5.66000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.226 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.191 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.196 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 16.679 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.961 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.938 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 7065 ; 0.019 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 6514 ; 0.003 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 9610 ; 1.966 ; 1.975 REMARK 3 BOND ANGLES OTHERS (DEGREES): 14976 ; 0.969 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 814 ; 6.992 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 331 ;34.945 ;23.837 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 1166 ;16.404 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 41 ;16.143 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 994 ; 0.122 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 7943 ; 0.013 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 1744 ; 0.011 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 299 A 860 REMARK 3 ORIGIN FOR THE GROUP (A): 11.4100 4.6310 22.6730 REMARK 3 T TENSOR REMARK 3 T11: 0.0073 T22: 0.5487 REMARK 3 T33: 0.3863 T12: 0.0031 REMARK 3 T13: 0.0229 T23: -0.0109 REMARK 3 L TENSOR REMARK 3 L11: 0.4190 L22: 0.9004 REMARK 3 L33: 6.4675 L12: -0.1565 REMARK 3 L13: -0.3683 L23: -0.2035 REMARK 3 S TENSOR REMARK 3 S11: -0.0470 S12: 0.1193 S13: 0.0093 REMARK 3 S21: 0.0142 S22: -0.0395 S23: 0.0568 REMARK 3 S31: 0.0371 S32: -0.3870 S33: 0.0865 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 299 B 860 REMARK 3 ORIGIN FOR THE GROUP (A): 12.4120 4.7900 60.1460 REMARK 3 T TENSOR REMARK 3 T11: 0.0295 T22: 0.5391 REMARK 3 T33: 0.4063 T12: 0.0230 REMARK 3 T13: 0.0258 T23: 0.0133 REMARK 3 L TENSOR REMARK 3 L11: 0.5956 L22: 0.9377 REMARK 3 L33: 2.6644 L12: -0.1244 REMARK 3 L13: -0.1537 L23: 0.3702 REMARK 3 S TENSOR REMARK 3 S11: -0.0072 S12: -0.0765 S13: 0.0845 REMARK 3 S21: -0.1154 S22: -0.0492 S23: -0.0241 REMARK 3 S31: 0.1406 S32: 0.0514 S33: 0.0564 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. U VALUES WITH TLS ADDED. RESIDUES 339 TO 349 IN CHAIN REMARK 3 A AND 339 TO 347 IN CHAIN B ARE DISORDERED. REMARK 4 REMARK 4 4UPN COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 17-JUN-14. REMARK 100 THE DEPOSITION ID IS D_1290060964. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-SEP-12 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 8.2.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.000 REMARK 200 MONOCHROMATOR : GRAPHITE REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 56296 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.090 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.9 REMARK 200 DATA REDUNDANCY : 3.400 REMARK 200 R MERGE (I) : 0.06000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 22.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.09 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.14 REMARK 200 COMPLETENESS FOR SHELL (%) : 90.5 REMARK 200 DATA REDUNDANCY IN SHELL : 3.10 REMARK 200 R MERGE FOR SHELL (I) : 0.37000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: OTHER REMARK 200 SOFTWARE USED: REFMAC REMARK 200 STARTING MODEL: NONE REMARK 200 REMARK 200 REMARK: RPIM 0.229 CC ONE HALF 0.898 REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.10 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.46 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20-22% PEG3350 0.1M MES, PH5.8 140-200 REMARK 280 MM AMMONIUM ACETATE 10% ETHYLENE GLYCOL 5 MM GSH 30UM SDS REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 26.03600 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 82.54800 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 55.63550 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 82.54800 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 26.03600 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 55.63550 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 9850 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 33580 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -86.9 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 CYS A 297 REMARK 465 PRO A 298 REMARK 465 SER A 339 REMARK 465 GLN A 340 REMARK 465 HIS A 341 REMARK 465 THR A 342 REMARK 465 ARG A 343 REMARK 465 LYS A 344 REMARK 465 PRO A 345 REMARK 465 GLU A 346 REMARK 465 ASP A 347 REMARK 465 VAL A 348 REMARK 465 ARG A 349 REMARK 465 GLY A 718 REMARK 465 CYS B 297 REMARK 465 PRO B 298 REMARK 465 SER B 339 REMARK 465 GLN B 340 REMARK 465 HIS B 341 REMARK 465 THR B 342 REMARK 465 ARG B 343 REMARK 465 LYS B 344 REMARK 465 PRO B 345 REMARK 465 GLU B 346 REMARK 465 ASP B 347 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 717 CA C O CB CG CD CE REMARK 470 LYS A 717 NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 VAL A 416 C VAL A 416 O 0.117 REMARK 500 TRP A 676 CG TRP A 676 CD1 0.105 REMARK 500 TRP B 421 CB TRP B 421 CG 0.114 REMARK 500 TYR B 441 CZ TYR B 441 CE2 0.123 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 410 NE - CZ - NH1 ANGL. DEV. = 4.5 DEGREES REMARK 500 ARG B 430 NE - CZ - NH1 ANGL. DEV. = 4.5 DEGREES REMARK 500 ARG B 430 NE - CZ - NH2 ANGL. DEV. = -3.5 DEGREES REMARK 500 ASP B 471 CB - CG - OD1 ANGL. DEV. = 5.6 DEGREES REMARK 500 ASP B 489 CB - CG - OD1 ANGL. DEV. = 5.4 DEGREES REMARK 500 ASP B 489 CB - CG - OD2 ANGL. DEV. = -5.5 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 309 -4.79 54.62 REMARK 500 ARG A 465 145.53 -34.53 REMARK 500 THR A 466 -88.90 -126.08 REMARK 500 ASP A 489 -44.97 -10.13 REMARK 500 CYS A 582 53.59 -160.95 REMARK 500 ARG A 603 -135.44 -118.30 REMARK 500 CYS A 672 107.70 -167.76 REMARK 500 ASP A 709 122.15 -33.27 REMARK 500 HIS A 714 158.22 -48.71 REMARK 500 ASP B 309 11.09 56.06 REMARK 500 ASP B 352 -69.21 -29.63 REMARK 500 SER B 392 -3.62 86.79 REMARK 500 ALA B 429 31.94 -99.94 REMARK 500 THR B 466 -88.19 -118.93 REMARK 500 CYS B 582 54.31 -154.53 REMARK 500 ARG B 603 -130.19 -115.74 REMARK 500 CYS B 672 98.22 -161.49 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 TYR B 588 MET B 589 148.80 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A1717 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS A 326 SG REMARK 620 2 CYS A 331 SG 111.1 REMARK 620 3 CYS B 326 SG 117.7 106.3 REMARK 620 4 CYS B 331 SG 105.2 103.2 112.4 REMARK 620 N 1 2 3 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 HEM A 750 FE REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS A 415 SG REMARK 620 2 HEM A 750 NA 90.5 REMARK 620 3 HEM A 750 NB 90.9 91.6 REMARK 620 4 HEM A 750 NC 92.3 177.1 89.2 REMARK 620 5 HEM A 750 ND 91.1 87.8 177.9 91.3 REMARK 620 N 1 2 3 4 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 HEM B 750 FE REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS B 415 SG REMARK 620 2 HEM B 750 NA 91.9 REMARK 620 3 HEM B 750 NB 94.2 89.1 REMARK 620 4 HEM B 750 NC 91.0 177.1 90.3 REMARK 620 5 HEM B 750 ND 88.7 91.0 177.1 89.5 REMARK 620 N 1 2 3 4 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE HEM A 750 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE H4B A 760 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 7LN A 800 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT A 860 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE HEM B 750 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE H4B B 760 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 7LN B 800 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT B 860 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN A 1717 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4UPM RELATED DB: PDB REMARK 900 STRUCTURE OF RAT NEURONAL NITRIC OXIDE SYNTHASE HEME DOMAIN IN REMARK 900 COMPLEX WITH (R)-1,2-BIS(N-(3-( METHOXYPHENYL)THIOPHENE-2- REMARK 900 CARBOXIMIDAMIDE))-PROPANE-3- AMINE REMARK 900 RELATED ID: 4UPO RELATED DB: PDB REMARK 900 STRUCTURE OF RAT NEURONAL NITRIC OXIDE SYNTHASE HEME DOMAIN IN REMARK 900 COMPLEX WITH N-[3-({[(3S,5S)-5-{[(3-{[(Z )-IMINO(THIOPHEN-2-YL) REMARK 900 METHYL]AMINO}BENZYL)OXY]METHYL }PYRROLIDIN-3-YL]OXY}METHYL)PHENYL] REMARK 900 THIOPHENE-2- CARBOXIMIDAMIDE REMARK 900 RELATED ID: 4UPP RELATED DB: PDB REMARK 900 STRUCTURE OF RAT NEURONAL NITRIC OXIDE SYNTHASE HEME DOMAIN IN REMARK 900 COMPLEX WITH N'-[4-[[(2S,4R)-4-[3-[(C- THIOPHEN-2-YLCARBONIMIDOYL) REMARK 900 AMINO]PHENOXY]PYRROLIDIN-2-YL ]METHOXY]PHENYL]THIOPHENE-2- REMARK 900 CARBOXIMIDAMIDE REMARK 900 RELATED ID: 4UPQ RELATED DB: PDB REMARK 900 STRUCTURE OF BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE HEME DOMAIN REMARK 900 IN COMPLEX WITH (R)-1,2-BIS(N-(3-( METHOXYPHENYL)THIOPHENE-2- REMARK 900 CARBOXIMIDAMIDE))-PROPANE-3- AMINE REMARK 900 RELATED ID: 4UPR RELATED DB: PDB REMARK 900 STRUCTURE OF BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE HEME DOMAIN REMARK 900 IN COMPLEX WITH (S)-1,2-BIS(N-(3-( METHOXYPHENYL)THIOPHENE-2- REMARK 900 CARBOXIMIDAMIDE))-PROPANE-3- AMINE REMARK 900 RELATED ID: 4UPS RELATED DB: PDB REMARK 900 STRUCTURE OF BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE HEME DOMAIN REMARK 900 IN COMPLEX WITH N-(3-((((2S,4S)-4-(((3 -(THIOPHENE-2- REMARK 900 CARBOXIMIDAMIDO)BENZYL)OXY)METHYL) PYRROLIDIN-2-YL)OXY)METHYL) REMARK 900 PHENYL)THIOPHENE-2- CARBOXIMIDAMIDE REMARK 900 RELATED ID: 4UPT RELATED DB: PDB REMARK 900 STRUCTURE OF BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE HEME DOMAIN REMARK 900 IN COMPLEX WITH N'-[4-[[(2S,4R)-4-[3 -[(C-THIOPHEN-2- REMARK 900 YLCARBONIMIDOYL)AMINO]PHENOXY]PYRROLIDIN -2-YL]METHOXY]PHENYL] REMARK 900 THIOPHENE-2-CARBOXIMIDAMIDE DBREF 4UPN A 297 718 UNP P29476 NOS1_RAT 297 718 DBREF 4UPN B 297 718 UNP P29476 NOS1_RAT 297 718 SEQRES 1 A 422 CYS PRO ARG PHE LEU LYS VAL LYS ASN TRP GLU THR ASP SEQRES 2 A 422 VAL VAL LEU THR ASP THR LEU HIS LEU LYS SER THR LEU SEQRES 3 A 422 GLU THR GLY CYS THR GLU HIS ILE CYS MET GLY SER ILE SEQRES 4 A 422 MET LEU PRO SER GLN HIS THR ARG LYS PRO GLU ASP VAL SEQRES 5 A 422 ARG THR LYS ASP GLN LEU PHE PRO LEU ALA LYS GLU PHE SEQRES 6 A 422 LEU ASP GLN TYR TYR SER SER ILE LYS ARG PHE GLY SER SEQRES 7 A 422 LYS ALA HIS MET ASP ARG LEU GLU GLU VAL ASN LYS GLU SEQRES 8 A 422 ILE GLU SER THR SER THR TYR GLN LEU LYS ASP THR GLU SEQRES 9 A 422 LEU ILE TYR GLY ALA LYS HIS ALA TRP ARG ASN ALA SER SEQRES 10 A 422 ARG CYS VAL GLY ARG ILE GLN TRP SER LYS LEU GLN VAL SEQRES 11 A 422 PHE ASP ALA ARG ASP CYS THR THR ALA HIS GLY MET PHE SEQRES 12 A 422 ASN TYR ILE CYS ASN HIS VAL LYS TYR ALA THR ASN LYS SEQRES 13 A 422 GLY ASN LEU ARG SER ALA ILE THR ILE PHE PRO GLN ARG SEQRES 14 A 422 THR ASP GLY LYS HIS ASP PHE ARG VAL TRP ASN SER GLN SEQRES 15 A 422 LEU ILE ARG TYR ALA GLY TYR LYS GLN PRO ASP GLY SER SEQRES 16 A 422 THR LEU GLY ASP PRO ALA ASN VAL GLN PHE THR GLU ILE SEQRES 17 A 422 CYS ILE GLN GLN GLY TRP LYS ALA PRO ARG GLY ARG PHE SEQRES 18 A 422 ASP VAL LEU PRO LEU LEU LEU GLN ALA ASN GLY ASN ASP SEQRES 19 A 422 PRO GLU LEU PHE GLN ILE PRO PRO GLU LEU VAL LEU GLU SEQRES 20 A 422 VAL PRO ILE ARG HIS PRO LYS PHE ASP TRP PHE LYS ASP SEQRES 21 A 422 LEU GLY LEU LYS TRP TYR GLY LEU PRO ALA VAL SER ASN SEQRES 22 A 422 MET LEU LEU GLU ILE GLY GLY LEU GLU PHE SER ALA CYS SEQRES 23 A 422 PRO PHE SER GLY TRP TYR MET GLY THR GLU ILE GLY VAL SEQRES 24 A 422 ARG ASP TYR CYS ASP ASN SER ARG TYR ASN ILE LEU GLU SEQRES 25 A 422 GLU VAL ALA LYS LYS MET ASP LEU ASP MET ARG LYS THR SEQRES 26 A 422 SER SER LEU TRP LYS ASP GLN ALA LEU VAL GLU ILE ASN SEQRES 27 A 422 ILE ALA VAL LEU TYR SER PHE GLN SER ASP LYS VAL THR SEQRES 28 A 422 ILE VAL ASP HIS HIS SER ALA THR GLU SER PHE ILE LYS SEQRES 29 A 422 HIS MET GLU ASN GLU TYR ARG CYS ARG GLY GLY CYS PRO SEQRES 30 A 422 ALA ASP TRP VAL TRP ILE VAL PRO PRO MET SER GLY SER SEQRES 31 A 422 ILE THR PRO VAL PHE HIS GLN GLU MET LEU ASN TYR ARG SEQRES 32 A 422 LEU THR PRO SER PHE GLU TYR GLN PRO ASP PRO TRP ASN SEQRES 33 A 422 THR HIS VAL TRP LYS GLY SEQRES 1 B 422 CYS PRO ARG PHE LEU LYS VAL LYS ASN TRP GLU THR ASP SEQRES 2 B 422 VAL VAL LEU THR ASP THR LEU HIS LEU LYS SER THR LEU SEQRES 3 B 422 GLU THR GLY CYS THR GLU HIS ILE CYS MET GLY SER ILE SEQRES 4 B 422 MET LEU PRO SER GLN HIS THR ARG LYS PRO GLU ASP VAL SEQRES 5 B 422 ARG THR LYS ASP GLN LEU PHE PRO LEU ALA LYS GLU PHE SEQRES 6 B 422 LEU ASP GLN TYR TYR SER SER ILE LYS ARG PHE GLY SER SEQRES 7 B 422 LYS ALA HIS MET ASP ARG LEU GLU GLU VAL ASN LYS GLU SEQRES 8 B 422 ILE GLU SER THR SER THR TYR GLN LEU LYS ASP THR GLU SEQRES 9 B 422 LEU ILE TYR GLY ALA LYS HIS ALA TRP ARG ASN ALA SER SEQRES 10 B 422 ARG CYS VAL GLY ARG ILE GLN TRP SER LYS LEU GLN VAL SEQRES 11 B 422 PHE ASP ALA ARG ASP CYS THR THR ALA HIS GLY MET PHE SEQRES 12 B 422 ASN TYR ILE CYS ASN HIS VAL LYS TYR ALA THR ASN LYS SEQRES 13 B 422 GLY ASN LEU ARG SER ALA ILE THR ILE PHE PRO GLN ARG SEQRES 14 B 422 THR ASP GLY LYS HIS ASP PHE ARG VAL TRP ASN SER GLN SEQRES 15 B 422 LEU ILE ARG TYR ALA GLY TYR LYS GLN PRO ASP GLY SER SEQRES 16 B 422 THR LEU GLY ASP PRO ALA ASN VAL GLN PHE THR GLU ILE SEQRES 17 B 422 CYS ILE GLN GLN GLY TRP LYS ALA PRO ARG GLY ARG PHE SEQRES 18 B 422 ASP VAL LEU PRO LEU LEU LEU GLN ALA ASN GLY ASN ASP SEQRES 19 B 422 PRO GLU LEU PHE GLN ILE PRO PRO GLU LEU VAL LEU GLU SEQRES 20 B 422 VAL PRO ILE ARG HIS PRO LYS PHE ASP TRP PHE LYS ASP SEQRES 21 B 422 LEU GLY LEU LYS TRP TYR GLY LEU PRO ALA VAL SER ASN SEQRES 22 B 422 MET LEU LEU GLU ILE GLY GLY LEU GLU PHE SER ALA CYS SEQRES 23 B 422 PRO PHE SER GLY TRP TYR MET GLY THR GLU ILE GLY VAL SEQRES 24 B 422 ARG ASP TYR CYS ASP ASN SER ARG TYR ASN ILE LEU GLU SEQRES 25 B 422 GLU VAL ALA LYS LYS MET ASP LEU ASP MET ARG LYS THR SEQRES 26 B 422 SER SER LEU TRP LYS ASP GLN ALA LEU VAL GLU ILE ASN SEQRES 27 B 422 ILE ALA VAL LEU TYR SER PHE GLN SER ASP LYS VAL THR SEQRES 28 B 422 ILE VAL ASP HIS HIS SER ALA THR GLU SER PHE ILE LYS SEQRES 29 B 422 HIS MET GLU ASN GLU TYR ARG CYS ARG GLY GLY CYS PRO SEQRES 30 B 422 ALA ASP TRP VAL TRP ILE VAL PRO PRO MET SER GLY SER SEQRES 31 B 422 ILE THR PRO VAL PHE HIS GLN GLU MET LEU ASN TYR ARG SEQRES 32 B 422 LEU THR PRO SER PHE GLU TYR GLN PRO ASP PRO TRP ASN SEQRES 33 B 422 THR HIS VAL TRP LYS GLY HET HEM A 750 43 HET H4B A 760 17 HET 7LN A 800 36 HET ACT A 860 4 HET ZN A1717 1 HET HEM B 750 43 HET H4B B 760 17 HET 7LN B 800 36 HET ACT B 860 4 HETNAM HEM PROTOPORPHYRIN IX CONTAINING FE HETNAM H4B 5,6,7,8-TETRAHYDROBIOPTERIN HETNAM 7LN N,N''-{[(2S)-3-AMINOPROPANE-1,2- HETNAM 2 7LN DIYL]BIS(OXYMETHANEDIYLBENZENE-3,1-DIYL)}DITHIOPHENE- HETNAM 3 7LN 2-CARBOXIMIDAMIDE HETNAM ACT ACETATE ION HETNAM ZN ZINC ION HETSYN HEM HEME FORMUL 3 HEM 2(C34 H32 FE N4 O4) FORMUL 4 H4B 2(C9 H15 N5 O3) FORMUL 5 7LN 2(C27 H29 N5 O2 S2) FORMUL 6 ACT 2(C2 H3 O2 1-) FORMUL 7 ZN ZN 2+ FORMUL 12 HOH *213(H2 O) HELIX 1 1 THR A 315 SER A 320 5 6 HELIX 2 2 THR A 350 ILE A 369 1 20 HELIX 3 3 SER A 374 SER A 392 1 19 HELIX 4 4 LYS A 397 ASN A 411 1 15 HELIX 5 5 GLY A 417 TRP A 421 5 5 HELIX 6 6 THR A 434 ASN A 451 1 18 HELIX 7 7 LYS A 452 ASN A 454 5 3 HELIX 8 8 ASN A 498 GLY A 509 1 12 HELIX 9 9 PRO A 537 VAL A 541 5 5 HELIX 10 10 PHE A 551 GLY A 558 5 8 HELIX 11 11 GLY A 590 VAL A 595 1 6 HELIX 12 12 ILE A 606 ASP A 615 1 10 HELIX 13 13 LYS A 620 SER A 623 5 4 HELIX 14 14 LEU A 624 ASP A 644 1 21 HELIX 15 15 ASP A 650 ARG A 669 1 20 HELIX 16 16 ASP A 675 VAL A 680 1 6 HELIX 17 17 SER A 684 THR A 688 5 5 HELIX 18 18 THR A 688 HIS A 692 5 5 HELIX 19 19 ASP A 709 HIS A 714 1 6 HELIX 20 20 THR B 315 SER B 320 5 6 HELIX 21 21 THR B 350 ILE B 369 1 20 HELIX 22 22 SER B 374 SER B 392 1 19 HELIX 23 23 LYS B 397 ASN B 411 1 15 HELIX 24 24 GLY B 417 TRP B 421 5 5 HELIX 25 25 THR B 434 ASN B 451 1 18 HELIX 26 26 LYS B 452 ASN B 454 5 3 HELIX 27 27 ASN B 498 GLY B 509 1 12 HELIX 28 28 PRO B 537 VAL B 541 5 5 HELIX 29 29 TRP B 553 GLY B 558 5 6 HELIX 30 30 GLY B 590 VAL B 595 1 6 HELIX 31 31 VAL B 595 ASP B 600 1 6 HELIX 32 32 ILE B 606 ASP B 615 1 10 HELIX 33 33 LYS B 620 SER B 623 5 4 HELIX 34 34 LEU B 624 ASP B 644 1 21 HELIX 35 35 ASP B 650 GLY B 670 1 21 HELIX 36 36 ASP B 675 VAL B 680 1 6 HELIX 37 37 SER B 684 THR B 688 5 5 HELIX 38 38 THR B 688 HIS B 692 5 5 HELIX 39 39 ASP B 709 THR B 713 5 5 SHEET 1 AA 2 LEU A 301 LYS A 304 0 SHEET 2 AA 2 VAL A 311 ASP A 314 -1 O LEU A 312 N VAL A 303 SHEET 1 AB 4 GLN A 425 ASP A 428 0 SHEET 2 AB 4 ALA A 458 ILE A 461 1 O ILE A 459 N PHE A 427 SHEET 3 AB 4 PHE A 584 SER A 585 -1 O SER A 585 N ALA A 458 SHEET 4 AB 4 ALA A 566 VAL A 567 -1 O VAL A 567 N PHE A 584 SHEET 1 AC 3 ARG A 473 VAL A 474 0 SHEET 2 AC 3 LEU A 522 GLN A 525 -1 O GLN A 525 N ARG A 473 SHEET 3 AC 3 GLU A 532 PHE A 534 -1 O GLU A 532 N LEU A 524 SHEET 1 AD 2 GLY A 484 LYS A 486 0 SHEET 2 AD 2 THR A 492 GLY A 494 -1 O LEU A 493 N TYR A 485 SHEET 1 AE 2 GLU A 543 PRO A 545 0 SHEET 2 AE 2 LYS A 560 TYR A 562 -1 O TRP A 561 N VAL A 544 SHEET 1 AF 3 LEU A 577 PHE A 579 0 SHEET 2 AF 3 LEU A 571 ILE A 574 -1 O LEU A 572 N PHE A 579 SHEET 3 AF 3 SER A 703 GLU A 705 -1 O SER A 703 N GLU A 573 SHEET 1 AG 2 TYR A 588 MET A 589 0 SHEET 2 AG 2 ILE A 648 VAL A 649 1 N VAL A 649 O TYR A 588 SHEET 1 BA 2 LEU B 301 LYS B 304 0 SHEET 2 BA 2 VAL B 311 ASP B 314 -1 O LEU B 312 N VAL B 303 SHEET 1 BB 4 GLN B 425 ASP B 428 0 SHEET 2 BB 4 ALA B 458 ILE B 461 1 O ILE B 459 N PHE B 427 SHEET 3 BB 4 PHE B 584 SER B 585 -1 O SER B 585 N ALA B 458 SHEET 4 BB 4 ALA B 566 VAL B 567 -1 O VAL B 567 N PHE B 584 SHEET 1 BC 3 ARG B 473 VAL B 474 0 SHEET 2 BC 3 LEU B 522 GLN B 525 -1 O GLN B 525 N ARG B 473 SHEET 3 BC 3 GLU B 532 PHE B 534 -1 O GLU B 532 N LEU B 524 SHEET 1 BD 2 GLY B 484 LYS B 486 0 SHEET 2 BD 2 THR B 492 GLY B 494 -1 O LEU B 493 N TYR B 485 SHEET 1 BE 2 GLU B 543 PRO B 545 0 SHEET 2 BE 2 LYS B 560 TYR B 562 -1 O TRP B 561 N VAL B 544 SHEET 1 BF 3 LEU B 577 PHE B 579 0 SHEET 2 BF 3 LEU B 571 ILE B 574 -1 O LEU B 572 N PHE B 579 SHEET 3 BF 3 SER B 703 GLU B 705 -1 O SER B 703 N GLU B 573 SHEET 1 BG 2 TYR B 588 MET B 589 0 SHEET 2 BG 2 ILE B 648 VAL B 649 1 N VAL B 649 O TYR B 588 LINK SG CYS A 326 ZN ZN A1717 1555 1555 2.32 LINK SG CYS A 331 ZN ZN A1717 1555 1555 2.23 LINK SG CYS A 415 FE HEM A 750 1555 1555 2.34 LINK ZN ZN A1717 SG CYS B 326 1555 1555 2.23 LINK ZN ZN A1717 SG CYS B 331 1555 1555 2.33 LINK SG CYS B 415 FE HEM B 750 1555 1555 2.46 CISPEP 1 THR A 701 PRO A 702 0 0.61 CISPEP 2 THR B 701 PRO B 702 0 -0.59 SITE 1 AC1 13 TRP A 409 ARG A 414 CYS A 415 SER A 457 SITE 2 AC1 13 TRP A 587 GLU A 592 TRP A 678 TYR A 706 SITE 3 AC1 13 H4B A 760 7LN A 800 ACT A 860 HOH A2094 SITE 4 AC1 13 HOH A2095 SITE 1 AC2 13 SER A 334 ARG A 596 VAL A 677 TRP A 678 SITE 2 AC2 13 HEM A 750 7LN A 800 HOH A2007 HOH A2070 SITE 3 AC2 13 HOH A2086 TRP B 676 PHE B 691 HIS B 692 SITE 4 AC2 13 GLU B 694 SITE 1 AC3 15 MET A 336 LEU A 337 PRO A 565 VAL A 567 SITE 2 AC3 15 PHE A 584 SER A 585 GLY A 586 TRP A 587 SITE 3 AC3 15 GLU A 592 HEM A 750 H4B A 760 HOH A2067 SITE 4 AC3 15 HOH A2069 HOH A2070 TRP B 306 SITE 1 AC4 4 TRP A 587 VAL A 649 HEM A 750 HOH A2025 SITE 1 AC5 13 TRP B 409 ARG B 414 CYS B 415 PHE B 584 SITE 2 AC5 13 SER B 585 TRP B 587 GLU B 592 TRP B 678 SITE 3 AC5 13 TYR B 706 H4B B 760 7LN B 800 HOH B2115 SITE 4 AC5 13 HOH B2116 SITE 1 AC6 14 TRP A 676 PHE A 691 HIS A 692 GLU A 694 SITE 2 AC6 14 SER B 334 MET B 336 ARG B 596 VAL B 677 SITE 3 AC6 14 TRP B 678 HEM B 750 7LN B 800 HOH B2004 SITE 4 AC6 14 HOH B2096 HOH B2109 SITE 1 AC7 13 TRP A 306 LEU B 337 PRO B 565 VAL B 567 SITE 2 AC7 13 PHE B 584 SER B 585 GLY B 586 TRP B 587 SITE 3 AC7 13 GLU B 592 TYR B 706 HEM B 750 H4B B 760 SITE 4 AC7 13 HOH B2096 SITE 1 AC8 3 GLY B 417 TRP B 587 HOH B2028 SITE 1 AC9 4 CYS A 326 CYS A 331 CYS B 326 CYS B 331 CRYST1 52.072 111.271 165.096 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019204 0.000000 0.000000 0.00000 SCALE2 0.000000 0.008987 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006057 0.00000